Below is a curated list of published studies related to different aspects of Attention Deficit / Hyperactivity Disorder (ADHD) in Saudi Arabia, including prevalence, awareness, diagnosis, language and communication, and review articles.
Additional studies from Saudi Arabia, including topics not featured on this page, are available in the research library. We also maintain a list of ADHD-related theses that have been made available online. If you would like your research featured here, or know of any publications in or about ADHD in KSA that you believe should be included here, please get in touch by email at research @ adhd.org.sa.
Note: Unless specifically stated, these studies were neither conducted by nor supported by the Saudi ADHD Society, and are provided as a resource for researchers only.
Review Articles
Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia
Abstract
To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.
Keywords
ADHD, featured, prevalence, psychiatry, riyadh, study, treatmentCitation
[research_citation style="APA" pubtype="journal" authors="Fatima A Al-Haidar," year="2003" title="Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia" volume="9" issue="0" journal="Easter Mediterranean Health Journal" shortjournal="East. Mediterr. Health J." startpage="988" endpage="995" articlenum="" doi=""]Link to this page: https://res.adhd.org.sa/doi/[/if 117]
Prevalence
Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia
Abstract
To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.
Keywords
ADHD, featured, prevalence, psychiatry, riyadh, study, treatmentCitation
[research_citation style="APA" pubtype="journal" authors="Fatima A Al-Haidar," year="2003" title="Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia" volume="9" issue="0" journal="Easter Mediterranean Health Journal" shortjournal="East. Mediterr. Health J." startpage="988" endpage="995" articlenum="" doi=""]Link to this page: https://res.adhd.org.sa/doi/[/if 117]
Awareness and Attitudes
Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia
Abstract
To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.
Keywords
ADHD, featured, prevalence, psychiatry, riyadh, study, treatmentCitation
[research_citation style="APA" pubtype="journal" authors="Fatima A Al-Haidar," year="2003" title="Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia" volume="9" issue="0" journal="Easter Mediterranean Health Journal" shortjournal="East. Mediterr. Health J." startpage="988" endpage="995" articlenum="" doi=""]Link to this page: https://res.adhd.org.sa/doi/[/if 117]
Diagnosis
Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia
Abstract
To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.
Keywords
ADHD, featured, prevalence, psychiatry, riyadh, study, treatmentCitation
[research_citation style="APA" pubtype="journal" authors="Fatima A Al-Haidar," year="2003" title="Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia" volume="9" issue="0" journal="Easter Mediterranean Health Journal" shortjournal="East. Mediterr. Health J." startpage="988" endpage="995" articlenum="" doi=""]Link to this page: https://res.adhd.org.sa/doi/[/if 117]
Language & Communication
Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia
Abstract
To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.
Keywords
ADHD, featured, prevalence, psychiatry, riyadh, study, treatmentCitation
[research_citation style="APA" pubtype="journal" authors="Fatima A Al-Haidar," year="2003" title="Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia" volume="9" issue="0" journal="Easter Mediterranean Health Journal" shortjournal="East. Mediterr. Health J." startpage="988" endpage="995" articlenum="" doi=""]Link to this page: https://res.adhd.org.sa/doi/[/if 117]